The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release.

[1]  F. Powrie,et al.  Dysregulated Hematopoietic Stem and Progenitor Cell Activity Promotes Interleukin-23-Driven Chronic Intestinal Inflammation , 2012, Immunity.

[2]  M. Bringer,et al.  Defects in autophagy favour adherent‐invasive Escherichia coli persistence within macrophages leading to increased pro‐inflammatory response , 2012, Cellular microbiology.

[3]  R. Green,et al.  miRNA-Mediated Gene Silencing by Translational Repression Followed by mRNA Deadenylation and Decay , 2012, Science.

[4]  A. Giraldez,et al.  Ribosome Profiling Shows That miR-430 Reduces Translation Before Causing mRNA Decay in Zebrafish , 2012, Science.

[5]  Aikaterini S. Papadopoulou,et al.  The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor , 2011, Nature Immunology.

[6]  Xiongfei Xu,et al.  The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ , 2011, Nature Immunology.

[7]  K. Ansel,et al.  MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. , 2011, Immunity.

[8]  S. Travis,et al.  IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease , 2011, The Journal of experimental medicine.

[9]  B. Becher,et al.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation , 2011, Nature Immunology.

[10]  K. Nakayama,et al.  miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. , 2011, Blood.

[11]  Ping-Chang Yang,et al.  The increased expression of IL‐23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity , 2011, Journal of leukocyte biology.

[12]  P. Rosenstiel,et al.  Nod2 is essential for temporal development of intestinal microbial communities , 2011, Gut.

[13]  M. Oosting,et al.  Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2 , 2011, Gut.

[14]  T. Luedde,et al.  Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis , 2011, Hepatology.

[15]  Gordon D. Brown,et al.  C-type lectins, fungi and Th17 responses , 2010, Cytokine & growth factor reviews.

[16]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[17]  Ryan M. O’Connell,et al.  MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. , 2010, Immunity.

[18]  F. Powrie,et al.  Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells , 2010, Immunity.

[19]  F. Nestle,et al.  Faculty Opinions recommendation of Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. , 2010 .

[20]  Oliver Distler,et al.  MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. , 2010, Arthritis and rheumatism.

[21]  P. Puccetti,et al.  Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction , 2010, Gut.

[22]  E. Pålsson-McDermott,et al.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 , 2010, Nature Immunology.

[23]  D. Philpott,et al.  Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.

[24]  D. Jewell,et al.  NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.

[25]  P. Mylona,et al.  Aox gene structure, transcript variation and expression in plants. , 2009, Physiologia plantarum.

[26]  J. Blanco,et al.  Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherent‐invasive E. coli (AIEC) in Crohn's disease , 2009, Inflammatory bowel diseases.

[27]  M. Netea,et al.  A Crohn's disease–associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1 , 2009, Nature Immunology.

[28]  A. Mantovani,et al.  Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals , 2009, Proceedings of the National Academy of Sciences.

[29]  Manuel A. S. Santos,et al.  MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells , 2009, Proceedings of the National Academy of Sciences.

[30]  G. Trinchieri,et al.  Regulation of interleukin‐12/interleukin‐23 production and the T‐helper 17 response in humans , 2008, Immunological reviews.

[31]  J. Schultze,et al.  CD25 as an immune regulatory molecule expressed on myeloid dendritic cells. , 2008, Immunobiology.

[32]  T. Petro,et al.  Promoter Analysis Reveals Critical Roles for SMAD-3 and ATF-2 in Expression of IL-23 p19 in Macrophages1 , 2008, The Journal of Immunology.

[33]  D. Hommes,et al.  Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. , 2007, Immunity.

[34]  Muller Fabbri,et al.  Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock1 , 2007, The Journal of Immunology.

[35]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[36]  G. Gores,et al.  mir-29 regulates Mcl-1 protein expression and apoptosis , 2007, Oncogene.

[37]  David Baltimore,et al.  MicroRNA-155 is induced during the macrophage inflammatory response , 2007, Proceedings of the National Academy of Sciences.

[38]  S. Schoenberg,et al.  Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: Results of a Prospective Study , 2006, Inflammatory bowel diseases.

[39]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[40]  F. Powrie,et al.  Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. , 2006, Immunity.

[41]  T. Mcclanahan,et al.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.

[42]  Francesco Bertoni,et al.  Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells , 2005, Nature Immunology.

[43]  A. Forbes,et al.  Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn’s disease , 2005, Gut.

[44]  T. Leist,et al.  Involvement of β-chemokines in the development of inflammatory demyelination , 2005, Journal of Neuroinflammation.

[45]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[46]  K. Fukase,et al.  Muramyldipeptide and diaminopimelic acid‐containing desmuramylpeptides in combination with chemically synthesized Toll‐like receptor agonists synergistically induced production of interleukin‐8 in a NOD2‐ and NOD1‐dependent manner, respectively, in human monocytic cells in culture , 2004, Cellular microbiology.

[47]  T. Leist,et al.  Involvement of β-chemokines in the development of inflammatory demyelination , 2005, Journal of Neuroinflammation.

[48]  M. Chamaillard,et al.  NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha defensin expression, J. Wehkamp, J. Harder, M. Weichenthal, M. Schwab, E. Schaeffeler, S. Schlee, in: Gut, 53. (2004), 1658 , 2004 .

[49]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[50]  M. Neurath,et al.  Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. , 2003, The Journal of clinical investigation.

[51]  A. Sher,et al.  Cutting Edge: Bradykinin Induces IL-12 Production by Dendritic Cells: A Danger Signal That Drives Th1 Polarization1 , 2003, The Journal of Immunology.

[52]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[53]  Alastair Forbes,et al.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. , 2002, Gastroenterology.

[54]  P. Ricciardi-Castagnoli,et al.  Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria , 2001, Nature Immunology.

[55]  S. Akira,et al.  Synergistic Effect of Muramyldipeptide with Lipopolysaccharide or Lipoteichoic Acid To Induce Inflammatory Cytokines in Human Monocytic Cells in Culture , 2001, Infection and Immunity.

[56]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.